In conclusion, we found that BMSCs may activatethe IL-6/STAT3 signaling pathway and promote cell invasion in Bel-7404cells, suggesting that this protumor effect should be seriously consideredbefore clinical application of MSC-mediated cancer therapy. This evidence concerns the gene IL6 and cancer.